| 期刊ISSN: | 2152-2650 |
|---|---|
| E-ISSN: | 2152-2669 |
| 影响因子: | 2.7 |
| 自引率: | 3.7% |
| 检索数据库: | |
| 出版语言: | 英文 |
| 期刊分类: |
| 最新中科院SCI期刊分区(基础版) | |
|---|---|
|
大学学科
|
|
|
医学
四区
|
|
|
按学科分区
|
|
|
血液学
四区
|
|
|
Top期刊
否
|
|
|
综述期刊
否
|
|
| 最新中科院SCI期刊分区(升级版) | |
|---|---|
|
大学学科
|
|
|
按学科分区
|
|
|
Top期刊
|
|
|
综述期刊
|
|
| 出版信息 | |
|---|---|
| 出版商 |
Cancer Media Group
|
| 期刊官网 | http://www.journals.elsevier.com/clinical-lymphoma-myeloma-and-leukemia |
| 涉及的研究方向 |
ONCOLOGY-HEMATOLOGY
|
| 年文章数 |
0
|
| 是否OA |
否
|
| APC费用 | |
| SCI期刊收录coverage | |
| 期刊简介 | |
|---|---|
|
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
|
|
| Cite Score相关 | |||
|---|---|---|---|
| Cite Score | SJR | SNIP | 排名 |
EI Compendex,Scopus,IEEE Xplore
第二届先进计算与智能机器人应用国际学术会议 (ACIRA 2026)IEEE出版
985主办
EI Compendex,Scopus,IEEE Xplore
第三届大数据分析与人工智能应用国际学术会议(BDAIA 2026)交叉学科
IEEE出版
EI Compendex,Scopus,IEEE Xplore
第二届AI赋能图像处理与计算机视觉技术国际学术研讨会(AIPCVT 2026)IEEE出版
多届检索